tiprankstipranks
Trending News
More News >
Genmab A/S (GMAB)
NASDAQ:GMAB
US Market
Advertisement

Genmab (GMAB) Technical Analysis

Compare
723 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Genmab A/S’s (GMAB) Moving Averages Convergence Divergence (MACD) indicator is 0.50, suggesting Genmab A/S is a Sell.
Genmab A/S’s (GMAB) 20-Day exponential moving average is 30.75, while Genmab A/S’s (GMAB) share price is $31.71, making it a Buy.
Genmab A/S’s (GMAB) 50-Day exponential moving average is 29.82, while Genmab A/S’s (GMAB) share price is $31.71, making it a Buy.

Genmab (GMAB) Pivot Points

Dec 04, 2025, 03:50 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
29.83
30.57
30.98
31.72
32.13
32.88
33.29
Fibonacci
30.57
31.01
31.28
31.72
32.17
32.44
32.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Genmab (GMAB) Moving Averages

Dec 04, 2025, 03:50 PM
Period
Simple
Exponential
MA5
31.76Sell
31.57Buy
MA10
31.10Buy
31.21Buy
MA20
30.36Buy
30.75Buy
MA50
30.61Buy
29.82Buy
MA100
27.46Buy
27.97Buy
MA200
24.14Buy
25.13Buy
Genmab A/S’s (GMAB) 10-Day exponential moving average is 31.21, while Genmab A/S’s (GMAB) share price is $31.71, making it a Buy.
Genmab A/S’s (GMAB) 100-Day exponential moving average is 27.97, while Genmab A/S’s (GMAB) share price is $31.71, making it a Buy.
Genmab A/S’s (GMAB) stock price is $31.71 and Genmab A/S’s (GMAB) 50-day simple moving average is 30.61, creating a Buy signal.
Genmab A/S’s (GMAB) stock price is $31.71 and Genmab A/S’s (GMAB) 100-day simple moving average is 27.46, creating a Buy signal.
Genmab A/S’s (GMAB) stock price is $31.71 and Genmab A/S’s (GMAB) 200-day simple moving average is 24.14, creating a Buy signal.

Genmab (GMAB) Technical Indicators

Dec 04, 2025, 03:50 PM
Name
Value
Implied Action
RSI (14)
60.72
Neutral
STOCH (9,6)
75.38
Neutral
STOCHRSI (14)
78.40
Neutral
MACD (12,26)
0.50
Sell
ADX (14)
23.71
Neutral
Williams %R
-27.40
Buy
CCI (14)
103.42
Sell
ATR (14)
0.76
-
Ultimate Oscillator
55.39
Neutral
ROC
4.62
Buy
Genmab A/S’s (GMAB) Relative Strength Index (RSI) is 60.72, creating a Neutral signal.
Genmab A/S’s (GMAB) Trend Strength Indicator (ADX) is 23.71, creating a Neutral signal.
Genmab A/S’s (GMAB) Commodity Channel Index (CCI) is 103.42, creating a Sell signal.
Genmab A/S’s (GMAB) Price Rate of Change (ROC) is 4.62, creating a Buy signal.

FAQ

Is GMAB a Buy, Hold, or Sell?
Based on GMAB’s technical indicators, GMAB is a Buy.
    What is GMAB’s RSI (14)?
    GMAB’s RSI (14) is 60.72, which suggests GMAB is a Neutral.
      What is GMAB’s MACD?
      GMAB’s MACD is 0.50, which suggests GMAB is a Sell.
        What is GMAB’s 5-day moving average?
        GMAB’s 5-day moving average is 31.76, which suggests GMAB is a Sell.
          What is GMAB’s 20-day moving average?
          GMAB 20-day moving average is 30.36, which suggests GMAB is a Buy.
            What is GMAB’s 50-day moving average?
            GMAB’s 50-day moving average is 30.61, which suggests GMAB is a Buy.
              What is GMAB’s 200-day moving average?
              GMAB’s 200-day moving average is 24.14, which suggests GMAB is a Buy.
                What is GMAB’s Williams % R (14)?
                GMAB’s Williams % R (14) is -27.40, which suggests GMAB is a Buy.
                  What is GMAB’s CCI (14)?
                  GMAB’s CCI (14) is 103.42, which suggests GMAB is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis